Bisphosphonate use for the management of breast cancer patients with bone metastases: A survey of Canadian Medical Oncologists

被引：0
|
作者：
Sunil Verma
Danielle Kerr-Cresswell
George Dranitsaris
Flay Charbonneau
Maureen Trudeau
Geetha Yogendran
Anne-Marie Cesta
Mark Clemons
机构：
[1] Toronto Sunnybrook Regional Cancer Centre and Cancer Care Ontario,Division of Medical Oncology
[2] Toronto-Sunnybrook Regional Cancer Centre,undefined
来源：
Supportive Care in Cancer | 2004年 / 12卷
关键词：
Bisphosphonates; Guidelines; Drug-use evaluation; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：852 / 858
页数：6
相关论文
共 50 条
  • [31] Reduction of metastases in breast cancer patients by adjuvant bisphosphonate treatment
    Diel, IJ
    Solomayer, EF
    Gollan, C
    Wallwiener, D
    Bastert, G
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S37 - S37
  • [32] A "report card" on medical oncologists and oncology nurses: survey of patients with metastatic breast cancer and companion surveys of medical oncologists and oncology nurses
    Love, NH
    Tripathy, D
    Carlson, R
    Kaderman, R
    Paley, D
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S136 - S136
  • [33] Breast Medical Oncologists' Perspectives of Telemedicine for Breast Cancer Care: A Survey Study
    Stavrou, Eleni
    Qiu, Jeanna
    Zafar, Affan
    Tramontano, Angela C.
    Isakoff, Steven
    Winer, Eric
    Schrag, Deborah
    Manz, Christopher
    JCO ONCOLOGY PRACTICE, 2022, 18 (09) : 668 - E1453
  • [34] Cost effectiveness of bisphosphonates in the management of breast cancer patients with bone metastases
    Botteman, M.
    Barghout, V.
    Stephens, J.
    Hay, J.
    Brandman, J.
    Aapro, M.
    ANNALS OF ONCOLOGY, 2006, 17 (07) : 1072 - 1082
  • [35] Cost effectiveness of bisphosphonates in the management of breast cancer patients with bone metastases
    Botteman, M.
    Barghout, V.
    Stephens, J.
    Hayl, J.
    Quednau, K.
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2006, 10 (03) : 227 - 227
  • [36] MANAGEMENT OF BREAST-CANCER WITH BONE METASTASES
    CLAVEL, M
    BONE, 1991, 12 : S11 - S12
  • [37] Extended Efficacy and Safety of Denosumab in Breast Cancer Patients with Bone Metastases Not Receiving Prior Bisphosphonate Therapy
    Lipton, Allan
    Steger, Guenther G.
    Figueroa, Jazmin
    Alvarado, Cristina
    Solal-Celigny, Philippe
    Body, Jean Jacques
    de Boer, Richard
    Berardi, Rossana
    Gascon, Pere
    Tonkin, Katia S.
    Coleman, Robert E.
    Paterson, Alexander H. G.
    Gao, Guozhi M.
    Kinsey, Amy C.
    Peterson, Mark C.
    Jun, Susie
    CLINICAL CANCER RESEARCH, 2008, 14 (20) : 6690 - 6696
  • [38] The incidence of atypical femoral fractures in breast cancer patients with bone metastases who received bisphosphonate treatment
    Nakata, Eiji
    Sugihara, Shinsuke
    Yamashita, Natsumi
    Osumi, Shozo
    JOURNAL OF ORTHOPAEDIC SCIENCE, 2017, 22 (05) : 946 - 950
  • [39] Impact of Bisphosphonate Therapy on Oral Health in Patients with Breast and Prostate Cancer and Bone Metastases: A Comprehensive Study
    Calik, Jacek
    Calik, Katarzyna
    Sauer, Natalia
    Zdzislaw, Bogucki
    Giedziun, Piotr
    Mackiewicz, Jacek
    Murawski, Marek
    Dziegiel, Piotr
    CANCERS, 2024, 16 (06)
  • [40] Bone-targeted agent use for bone metastases from breast cancer and prostate cancer: A patient survey
    Hutton, Brian
    Morretto, Patricia
    Emmenegger, Urban
    Mazzarello, Sasha
    Kuchuk, Iryna
    Addison, Christina L.
    Crawley, Freya
    Canil, Christine
    Malone, Shawn
    Berry, Scott
    Fergusson, Dean
    Clemons, Mark
    JOURNAL OF BONE ONCOLOGY, 2013, 2 (03): : 105 - 109
12345